Nkeiruka Nnam, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 540 25th Ave, Bellwood, IL 60104 Phone: 708-544-1199 Fax: 708-544-2934 |
News Archive
Now is the time for healthcare innovators to adopt plastic electronics and revolutionise healthcare monitoring and diagnosis. InnovationDB, the world's largest IP licensable technology database, has carried out a comprehensive study of the use of plastic electronics in healthcare devices to spot the biggest trends and identify the full potential of this exciting technology to transform our lives.
Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.
XenoPort, Inc. announced today that the first subjects have been dosed in a Phase 1, randomized, double-blind, two-period crossover, food effect comparison study of XP23829 in healthy adults. The trial is designed to assess the pharmacokinetics, safety and tolerability of a single dose of XP23829 administered in both fasted and fed conditions.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced the initiation of a Phase 2a clinical trial to evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent C. difficile infection (CDI).
Spanish-speaking women encounter unique challenges when receiving notifications regarding their mammogram results and breast density.
› Verified 5 days ago